EVALUATION OF A NOVEL DUAL ANTIFIBROTIC AND PROREGENERATIVE STRATEGY TO FACILITATE IMPROVED FUNCTIONAL OUTCOMES IN THE TREATMENT OF VOLUMETRIC MUSCLE LOSS
$1,998,062FY2021Defense Health AgencyDOD
The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc.